Ardelyx Inc. Shares Surge Past 200-Day Moving Average, Trading Up 14.2%
PorAinvest
martes, 5 de agosto de 2025, 12:10 pm ET1 min de lectura
ARDX--
The move comes as Ardelyx Inc reported its Q2 2025 earnings, which exceeded analysts’ expectations. The company posted a net loss of $0.08 per share, beating the forecasted $0.13 loss. Revenue reached $97.7 million, surpassing the forecast of $82.51 million, representing an 18.41% surprise [2].
The company’s strong performance is driven by the success of its key products, IBSRELA and EXPOSA. IBSRELA net sales grew by 84% year-over-year, while EXPOSA net sales increased by 7% quarter-over-quarter. Ardelyx has also raised its full-year revenue guidance for IBSRELA to $250-$260 million, signaling optimism about sustained demand [2].
The stock remains below its 52-week high of $7.18 but is significantly above its 52-week low of $3.21. While the stock has experienced a -21.56% return over the past six months, the modest stock movement reflects investor confidence in the company’s performance and future prospects [2].
References:
[1] https://www.nasdaq.com/articles/ardelyx-ardx-shares-cross-above-200-dma
[2] https://za.investing.com/news/transcripts/earnings-call-transcript-ardelyx-q2-2025-beats-earnings-expectations-93CH-3818942
Ardelyx Inc (ARDX) shares have crossed above their 200-day moving average of $4.87, reaching $5.49 per share. The stock is up 14.2% on the day, with a 52-week low of $3.21 and a high of $7.18.
Ardelyx Inc (ARDX) shares have crossed above their 200-day moving average of $4.87, reaching $5.49 per share. The stock is up 14.2% on the day, with a 52-week low of $3.21 and a high of $7.18 [1].The move comes as Ardelyx Inc reported its Q2 2025 earnings, which exceeded analysts’ expectations. The company posted a net loss of $0.08 per share, beating the forecasted $0.13 loss. Revenue reached $97.7 million, surpassing the forecast of $82.51 million, representing an 18.41% surprise [2].
The company’s strong performance is driven by the success of its key products, IBSRELA and EXPOSA. IBSRELA net sales grew by 84% year-over-year, while EXPOSA net sales increased by 7% quarter-over-quarter. Ardelyx has also raised its full-year revenue guidance for IBSRELA to $250-$260 million, signaling optimism about sustained demand [2].
The stock remains below its 52-week high of $7.18 but is significantly above its 52-week low of $3.21. While the stock has experienced a -21.56% return over the past six months, the modest stock movement reflects investor confidence in the company’s performance and future prospects [2].
References:
[1] https://www.nasdaq.com/articles/ardelyx-ardx-shares-cross-above-200-dma
[2] https://za.investing.com/news/transcripts/earnings-call-transcript-ardelyx-q2-2025-beats-earnings-expectations-93CH-3818942
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios